Tags |
|
|
Links |
|
|
Top Articles - A Murky Crystal Ball
While the early results of earnings season may not be giving investors much to cheer about, it is a nice diversion to the stock market
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
's May-June sell-off.
And like a much needed summer holiday, it may be just the break penny stock investor's need before heading into
And like a much needed summer holiday, it may be just the break penny stock investor's need before heading into
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
the autumn trading season. But until then, we must weather a turbulent earnings season.
Now, I'm not sure if your favorite penny st
Now, I'm not sure if your favorite penny st
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ck company has announced their quarterly results yet, but I have noticed that there seems to be something missing at the end of (some
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
of) the reports. And it's making my ability to predict the future that much more difficult.
Typically, at the end of an earnings rep
Typically, at the end of an earnings rep
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
rt, a company will finish off teasingly with a "forecast" or an "outlook" for the next quarter and sometimes the remainder of the year
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
. Something that will make us stick by their side through thick and thin.
Unfortunately, market volatility and ever growing geopolit
Unfortunately, market volatility and ever growing geopolit
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ical tensions are making it tougher for companies to predict what's going on quarter-to-quarter.
Lebanon may not be an economic power
Lebanon may not be an economic power
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ouse that's part of your water cooler banter...but last week's Israeli bombing was enough to shake global markets. In addition, oil p
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
rices hit a new record and the Vix index of U.S. stock-market volatility shot up 29% in a week.
It's tough enough trying to accuratel
It's tough enough trying to accuratel
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
predict how well your company is going to do quarter-to-quarter when times are good. Throw in rising tensions in the Middle East, a
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
depressed market, and an all too present hurricane season, and you've got a murky crystal ball.
Why? When consumers get strained by
Why? When consumers get strained by
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
higher prices and pay more to borrow, investors are worried that they'll have less to spend; lowering overall demand for good and serv
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ces. In return, some businesses need to absorb higher costs without scaring away customers. And customers like you and me are the on
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
es that impact a company's earnings.
Still, penny stock investors ought not be too nervous about market jitters. Penny stock compani
Still, penny stock investors ought not be too nervous about market jitters. Penny stock compani
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s, by their very nature, can take advantage of changing economic conditions and opportunities better than big companies.
And a jitter
And a jitter
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
y market means there are still lots of good buying opportunities out there. There is obvious strength in oil and gas and precious met
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
als. But for penny stock investors, you want to find something that isn’t obvious. Or at least isn't obvious to the rest of the inve
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ting herd.
Predicting the future of the stock market day-to-day is difficult enough, let alone trying to guess what you're going to d
Predicting the future of the stock market day-to-day is difficult enough, let alone trying to guess what you're going to d
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
o quarter-to-quarter; unless your name is Marty McFly, you own a De Lorean, and have a flux capacitor. In which case, we need to talk
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/103204/toparticles-A-Murky-Crystal-Ball.html">A Murky Crystal Ball</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/103204/toparticles-A-Murky-Crystal-Ball.html]A Murky Crystal Ball[/url]
Related Articles:
Digital Mass Flow Control Accessories
Your Web Site — Losing Business or Growing Business
Bookmark it:
|